Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1980 1
1981 3
1988 4
1989 3
1990 7
1991 6
1992 9
1993 4
1994 5
1995 7
1996 8
1997 17
1998 10
1999 21
2000 10
2001 13
2002 13
2003 9
2004 19
2005 12
2006 20
2007 22
2008 19
2009 28
2010 21
2011 33
2012 31
2013 27
2014 30
2015 25
2016 24
2017 24
2018 23
2019 18
2020 38
2021 21
Text availability
Article attribute
Article type
Publication date

Search Results

524 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for kawada, n[au]
Your search for Kawadai N[au] retrieved no results
Ultrasensitive ELISA Developed for Diagnosis.
Iha K, Inada M, Kawada N, Nakaishi K, Watabe S, Tan YH, Shen C, Ke LY, Yoshimura T, Ito E. Iha K, et al. Among authors: kawada n. Diagnostics (Basel). 2019 Jul 18;9(3):78. doi: 10.3390/diagnostics9030078. Diagnostics (Basel). 2019. PMID: 31323782 Free PMC article. Review.
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.
Qi X, Liu Y, Wang J, Fallowfield JA, Wang J, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Li X, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Li X, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Li X, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC; COVID-Cirrhosis-CHESS Group. Qi X, et al. Among authors: kawada n. Gut. 2021 Feb;70(2):433-436. doi: 10.1136/gutjnl-2020-321666. Epub 2020 May 20. Gut. 2021. PMID: 32434831 Free PMC article. No abstract available.
TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
Okina Y, Sato-Matsubara M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thanh Thuy LT, Ichikawa H, Minamiyama Y, Kadota M, Fujii H, Enomoto M, Ikeda K, Yoshizato K, Pinzani M, Kawada N. Okina Y, et al. Among authors: kawada n. J Hepatol. 2020 Oct;73(4):882-895. doi: 10.1016/j.jhep.2020.03.051. Epub 2020 Apr 21. J Hepatol. 2020. PMID: 32330605 Free article.
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
Honda A, Tanaka A, Kaneko T, Komori A, Abe M, Inao M, Namisaki T, Hashimoto N, Kawata K, Takahashi A, Ninomiya M, Kang JH, Arakawa M, Yamagiwa S, Joshita S, Umemura T, Sato K, Kaneko A, Kikuchi K, Itakura J, Nomura T, Kakisaka K, Fujii H, Kawada N, Takikawa Y, Masaki T, Ohira H, Mochida S, Yoshiji H, Iimuro S, Matsuzaki Y, Takikawa H; Japan PBC Study Group. Honda A, et al. Among authors: kawada n. Hepatology. 2019 Dec;70(6):2035-2046. doi: 10.1002/hep.30552. Epub 2019 Apr 12. Hepatology. 2019. PMID: 30737815
[Interferon].
Tamori A, Kawada N. Tamori A, et al. Among authors: kawada n. Nihon Rinsho. 2012 Apr;70(4):620-4. Nihon Rinsho. 2012. PMID: 22568143 Review. Japanese.
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: kawada n. BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2. BMC Gastroenterol. 2012. PMID: 22221544 Free PMC article.
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.
Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group. Qi X, et al. Among authors: kawada n. Hepatol Int. 2020 Jul;14(4):478-482. doi: 10.1007/s12072-020-10051-z. Epub 2020 May 22. Hepatol Int. 2020. PMID: 32440857 Free PMC article.
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study.
Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. Among authors: kawada n. J Gastroenterol. 2021 Jan;56(1):67-77. doi: 10.1007/s00535-020-01733-4. Epub 2020 Oct 1. J Gastroenterol. 2021. PMID: 33001338
Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.
Odagiri N, Hai H, Thuy LTT, Dong MP, Suoh M, Kotani K, Hagihara A, Uchida-Kobayashi S, Tamori A, Enomoto M, Kawada N. Odagiri N, et al. Among authors: kawada n. Cancers (Basel). 2020 Jul 24;12(8):2045. doi: 10.3390/cancers12082045. Cancers (Basel). 2020. PMID: 32722224 Free PMC article.
524 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page